Channels Recombinant Salmonella enterica serovar Typhimurium vaccine vector expressing green fluorescent protein as a model antigen or human immunodeficiency virus type 1 subtype C Gag
Construction, stability and immunogenicity of recombinant BCG expressing HIV-1 subtype C gag under the control of MtrA promoter, with or without the leader sequences
An epidemiological study of Salmonella enterica serovar Enteritidis in South Africa
The characterisation and expression of HIV-1 subtype C gag
Recombinant BCG expressing HIV-1 C GAG : selection of the vaccine gene and construction and evaluation as a vaccine candidate
Risk assessment of Escherichia coli O157:h7, Listeria monocytogenes, Salmonella enterica subsp. Enterica serovar typhimurium and Staphylococcus aureus within a stone fruit production environment
Antibiotic Susceptibility Pattern of Salmonella Enterica Serovar Typhi Isolated from Suspected Typhoid Fever Cases in General Hospital Minna
Use of Salmonella enterica Serovar Typhi Hemolysin E and Lipopolysaccharide IgA to Identify Enteric Fever Cases, South Asia
A Comparison of Fluorescent Microscopy Methods for the Detection of Chlamydia trachomatis
Prokaryotic Production of Human Immunodeficiency VirusType 1 Subtype C Tat, Nef and Reverse Transcriptase andInvestigation of Antibody Responses to these proteins inHIV-1 Infected Individuals as well as Macaques Vaccinatedwith SAAVI DNA-C/C2 and SAAV
The Influence of HIV-1 Subtype C LTR Genotype on Latency Potential
The development of novel HIV-1 vaccines using modified recombinant BCG
Recombinant BCG expressing rotavirus VP6 : construction and evaluation as an anti-rotavirus vaccine
Evaluation of a reverse tetracycline inducible system in recombinant BCG to improve stability and immunogenicity
Evolution of HIV-1 subtype C immune responses during acute and chronic HIV infection
The role of early cytotoxic lymphocyte (CTL) escape in the pathogenesis of HIV-1 subtype C infection
Characterization of genotypic and phenotypic properties of transmitted Human Immunodeficiency virus type 1 variants circulating in Mbeya Tanzania
Adaptive changes in HIV-1 subtype c proteins during early infection and their effect on disease progression
Investigating cross-clade immune responses in HIV-1 subtype C-infected individuals from South Africa
Impact of Cytotoxic T Lymphocyte (CTL) escape mutations in acute/Early HIV-1 Subtype C Infection on Disease Progression
Generation and characterization of HIV-1 subtype C candidate vaccines that will induce high titre antibody responses to HIV-1 envelope glycoprotein
Investigating cross-clade immune responses in HIV-1 subtype C-infected individuals from South Africa: implications for HIV vaccine design
Investigation of the use of recombinant BCG, expressing the major capsid protein (LI) of human papillomavirus type 16, as a candidate vaccine for cervical cancer
Comparison of the two lumpy skin disease virus vaccines, Neethling and Herbivac, and construction of a recombinant Herbivac-Rift Valley fever virus vaccine
A study of HIV-1 dual infection in a cohort of subtype C infected sex workers : viral evolution and its association with disease progression
Improvement of the Capripoxvirus, lumpy skin disease virus for use as a vaccine vector
Investigation of local South African avipoxviruses as potential vaccine vectors
Recombinant BCG expressing rotavirus VP6 : construction and evaluation as an anti-rotavirus vaccine
Development and characterisation of recombinant LSDV-vectored dual vaccines against bovine leukaemia virus and lumpy skin disease virus
Investigation of recombinant BCG as a vector to deliver HPV-11 L1 vaccines
A study of host genetic determinants of human papillomavirus (HPV) infection, cervical cancer and herpes simplex virus type-2 (HSV-2) infection
An investigation into improved HIV-1 subtype C envelope based vaccine design
The development of novel HIV-1 vaccines using modified recombinant BCG
The development of penguinpox virus (PEPV) as a vaccine vector : transfer vector construction and rescue of virus growth in rabbit kidney cells (RK-13) by vaccinia virus K1
A study of the host-restricted lumpy skin disease virus as a vaccine vector using rabies babies virus as a model
A Study of Genital Human Papillomavirus (HPV) and Evaluation of HPV Testing for Cervical Cancer Screening in Women from the Eastern Cape Province, South Africa
Investigation of the use of recombinant BCG, expressing the major capsid protein (LI) of human papillomavirus type 16, as a candidate vaccine for cervical cancer
Recombinant Salmonella enterica serovar Typhimurium vaccine vector expressing green fluorescent protein as a model antigen or human immunodeficiency virus type 1 subtype C Gag
An investigation into the Use of Lumpy Skin Disease Virus as a Vaccine Vector for a Potential HIV-1 vaccine
Generation and characterization of HIV-1 subtype C candidate vaccines that will induce high titre antibody responses to HIV-1 envelope glycoprotein
A study of genital human papillomavirus (HPV) infection and antibody response in heterosexually active South African couples
The development of recombinant lumpy skin disease virus vaccines for foot-and-mouth disease and rift valley fever
Comparison of the two lumpy skin disease virus vaccines, Neethling and Herbivac, and construction of a recombinant Herbivac-Rift Valley fever virus vaccine
Genetic and phenotypic analysis of novel South African Avian poxviruses
Characterisation and evolutionary dynamics of ten novel Gammapapillomavirus types from South African penile swabs
Pre-clinical assessment of novel candidate HIV-1 vaccines using the Chacma baboon
Genetic characterisation of six novel African swine fever viruses isolated from a pig, warthog, wild boar, and ticks
A study of Human Papillomavirus (HPV) types in young South African women and HPV variants in South African couples
Recombinant BCG expressing HIV-1 C GAG : selection of the vaccine gene and construction and evaluation as a vaccine candidate
